135 related articles for article (PubMed ID: 14743743)
1. [Genetic tests for molecular markers of cancer].
Miyachi H; Asai S
Rinsho Byori; 2003 Dec; 51(12):1195-202. PubMed ID: 14743743
[TBL] [Abstract][Full Text] [Related]
2. DualChip microarray as a new tool in cancer research.
Gillet JP; de Longueville F; Remacle J
Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
[TBL] [Abstract][Full Text] [Related]
3. [Tumor associated biomarker for early diagnosis of cancer].
Ohkura H
Nihon Rinsho; 1996 May; 54(5):1281-5. PubMed ID: 8965352
[TBL] [Abstract][Full Text] [Related]
4. [The present status and future prospect of the molecular diagnostic tests].
Miyachi H
Rinsho Byori; 2001 Feb; 49(2):139-49. PubMed ID: 11307306
[TBL] [Abstract][Full Text] [Related]
5. Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies.
Tzankov A; Went P; Zimpfer A; Dirnhofer S
Exp Gerontol; 2005; 40(8-9):737-44. PubMed ID: 16125349
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.
Rhodes DR; Chinnaiyan AM
Ann N Y Acad Sci; 2004 May; 1020():32-40. PubMed ID: 15208181
[TBL] [Abstract][Full Text] [Related]
7. Individualized cancer therapy: molecular approaches to the prediction of tumor response.
McLeod HL
Expert Rev Anticancer Ther; 2002 Feb; 2(1):113-9. PubMed ID: 12113060
[TBL] [Abstract][Full Text] [Related]
8. cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance.
Villeneuve DJ; Hembruff SL; Veitch Z; Cecchetto M; Dew WA; Parissenti AM
Breast Cancer Res Treat; 2006 Mar; 96(1):17-39. PubMed ID: 16322897
[TBL] [Abstract][Full Text] [Related]
9. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
10. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
12. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic developments involving cell-free (circulating) nucleic acids.
Tong YK; Lo YM
Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
[TBL] [Abstract][Full Text] [Related]
14. [Molecular diagnosis in oncology].
Imianitov EN
Mol Biol (Mosk); 2008; 42(5):772-85. PubMed ID: 18988527
[TBL] [Abstract][Full Text] [Related]
15. [Genomic markers and anticancer chemotherapy].
Nishiyama M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):194-9. PubMed ID: 18281756
[TBL] [Abstract][Full Text] [Related]
16. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract][Full Text] [Related]
17. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-based "omics" technologies in cancer diagnostics.
Zhang X; Wei D; Yap Y; Li L; Guo S; Chen F
Mass Spectrom Rev; 2007; 26(3):403-31. PubMed ID: 17405143
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
Ianov IuK; Novik AA; Belokhvostov AS
Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
[No Abstract] [Full Text] [Related]
20. Commercialized multigene predictors of clinical outcome for breast cancer.
Ross JS; Hatzis C; Symmans WF; Pusztai L; Hortobágyi GN
Oncologist; 2008 May; 13(5):477-93. PubMed ID: 18515733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
